Spanish drugmaker Grifols SA is facing restrictions on its Canadian licence to collect blood products following the deaths of two patients who made plasma donations in the country. Health Canada, ... Grifols is a leading global healthcare company.
Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives. Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ... Mena FN: Health Coalition Demands Disclosures & End To Grifols' For-Profit Blood Plasma Contract Following Reports Of Deaths, Harm, Non-Compliance Health Coalition Demands Disclosures & End To Grifols' For-Profit Blood Plasma Contract Following Reports Of Deaths, Harm, Non-Compliance MADRID, June 7 (Reuters) - Spain's Grifols has agreed to buy U.S.-based Talecris Biotherapeutics , which makes plasma-based protein medicines, for $3.4 billion in a bold move to expand its business in ...
